The story of Viagra presents a interesting case for stakeholders in the medicinal sector. While initially a blockbuster success, creating billions, the patent lapse and the subsequent entry of off-brand competitors https://onlinepharmacy575218.ssnblog.com/40361475/the-little-copyright-and-pharma-a-hazardous-play